ALX ONCOLOGY HOLDINGS INC (ALXO) ROI
- 2026-06-30: ROI -55.45%.
- 2026-03-31: ROI -55.59%.
- 2025-12-31: ROI -284.62%.
- 2025-09-30: ROI -196.70%.
Complete source-backed roi history.
- Available history
- 2020-06-30 to 2026-06-30
- Data captured
Historical ROI
| Date | ROI |
|---|---|
| 2026-06-30 | -55.45% |
| 2026-03-31 | -55.59% |
| 2025-12-31 | -284.62% |
| 2025-09-30 | -196.70% |
| 2025-06-30 | -156.57% |
| 2025-03-31 | -132.32% |
| 2024-12-31 | -109.17% |
| 2024-09-30 | -103.08% |
| 2024-06-30 | -101.39% |
| 2024-03-31 | -95.57% |
| 2023-12-31 | -80.66% |
| 2023-09-30 | -81.90% |
| 2023-06-30 | -58.67% |
| 2023-03-31 | -51.69% |
| 2022-12-31 | -45.26% |
| 2020-09-30 | -13.47% |
| 2020-06-30 | 35.04% |
Annual ROI
| Date | ROI |
|---|---|
| 2025-12-31 | -284.62% |
| 2024-12-31 | -109.17% |
| 2023-12-31 | -80.66% |
| 2022-12-31 | -45.26% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 |